Alterations in estrogen signalling pathways upon acquisition of anthracycline resistance in breast tumor cells.
Intrinsic or acquired drug resistance is a major impediment to the successful treatment of women with breast cancer using chemotherapy. We have observed that MCF-7 breast tumor cells selected for resistance to doxorubicin or epirubicin (MCF-7DOX2 and MCF-7EPI cells, respectively) exhibited increased...
Main Authors: | Simon Chewchuk, Baoqing Guo, Amadeo Mark Parissenti |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5308870?pdf=render |
Similar Items
-
Distinct genetic alterations occur in ovarian tumor cells selected for combined resistance to carboplatin and docetaxel
by: Armstrong Stephen R, et al.
Published: (2012-11-01) -
Inflammatory cytokine production in tumor cells upon chemotherapy drug exposure or upon selection for drug resistance.
by: Derek W Edwardson, et al.
Published: (2017-01-01) -
Role of drug transporters and drug accumulation in the temporal acquisition of drug resistance
by: Veitch Zachary, et al.
Published: (2008-11-01) -
Estrogen receptor signaling regulates the expression of the breast tumor kinase in breast cancer cells
by: Sayem Miah, et al.
Published: (2019-01-01) -
Estrogen-dependent signaling pathways and their role in the tumor progression: progress and perspectives
by: M. A. Krasil’nikov, et al.
Published: (2015-06-01)